Methods
Published on 05 Oct 2023
Regorafenib alone or in combination with high/low-dose radiotherapy plus toripalimab as third-line treatment in patients with metastatic colorectal cancer: protocol for a prospective, randomized, controlled phase II clinical trial (SLOT)
in Gastrointestinal Cancers: Colorectal Cancer
- 3,073 views
- 3 citations